HF
EPZM

HRT Financial’s Epizyme, Inc EPZM Stock Holding History

HRT Financial’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-567,836
Closed -$1.42M – 4164
2021
Q4 		$1.42M Buy
567,836
+458,308
+418% +$1.8M 0.01% 874
2021
Q3 		$560K Buy
109,528
+42,149
+63% +$256K ﹤0.01% 1876
2021
Q2 		$559K Buy
67,379
+29,944
+80% +$252K 0.01% 1655
2021
Q1 		$326K Buy
37,435
+19,381
+107% +$201K ﹤0.01% 2053
2020
Q4 		$196K Buy
+18,054
New +$223K ﹤0.01% 1500

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's EPZM Position: Q1 2022 in Review

HRT Financial sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 567,836 shares — an estimated $1.42M sold.

HRT Financial first reported a position in EPZM in Q4 2020 and held it in 5 quarters. The position peaked at $1.42M in Q4 2021. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • HRT Financial reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • HRT Financial sold 567,836 Epizyme, Inc shares in Q1 2022, an estimated $1.42M.
  • HRT Financial first reported a position in Epizyme, Inc in Q4 2020 and held it in 5 quarters.
  • HRT Financial's Epizyme, Inc position peaked at $1.42M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.